These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9250794

  • 1. Somatostatin receptor scintigraphy in the staging of lymphomas.
    Ivancević V, Wörmann B, Nauck C, Sandrock D, Munz DL, Hiddemann W, Emrich D.
    Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
    Lugtenburg PJ, Löwenberg B, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, van Putten WL, Krenning EP.
    J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
    [Abstract] [Full Text] [Related]

  • 3. The relevance of somatostatin receptor expression in malignant lymphomas.
    van den Anker-Lugtenburg PJ, Löwenberg B, Lamberts SW, Krenning EP.
    Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
    [Abstract] [Full Text] [Related]

  • 4. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
    Sarda L, Duet M, Zini JM, Berolatti B, Benelhadj S, Tobelem G, Mundler O.
    Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
    [Abstract] [Full Text] [Related]

  • 5. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ.
    J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
    van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Van Hagen MP, Gerrits CJ, Reubi JC, Lamberts SW, Löwenberg B.
    Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
    [Abstract] [Full Text] [Related]

  • 7. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
    Lipp RW, Schnedl WJ, Aglas F, Ranner G, Beham-Schmid C, Leb G, Sill H.
    Acta Med Austriaca; 1999 Apr; 26(3):105-8. PubMed ID: 10520379
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin analogue scintigraphy of malignant lymphomas.
    Vanhagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Löwenberg B, Lamberts SW.
    Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin-receptor imaging in lymphoma.
    Goldsmith SJ, Macapinlac HA, O'Brien JP.
    Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.
    Lugtenburg PJ, Krenning EP, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, van Putten WL, Löwenberg B.
    Br J Haematol; 2001 Mar; 112(4):936-44. PubMed ID: 11298588
    [Abstract] [Full Text] [Related]

  • 11. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A, Berg R.
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [Abstract] [Full Text] [Related]

  • 12. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
    Monzawa S, Karikomi M, Uno K, Itami J, Arimizu N.
    Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G, Farlow DC, Antico VF, Gruenewald SM, Boyages J.
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [Abstract] [Full Text] [Related]

  • 16. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
    Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME.
    J Nucl Med; 1997 Mar; 38(3):343-8. PubMed ID: 9074514
    [Abstract] [Full Text] [Related]

  • 17. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B, Gilday DL, Ash JM.
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, Pisu N, Madeddu G, Delle Fave G, Madeddu G.
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
    Krause T, Eisenmann N, Reinhardt M, Bathmann J, Altehoefer C, Finke J, Moser E.
    Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
    [Abstract] [Full Text] [Related]

  • 20. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ, Papandrianos NI, Symeonidis A, Spyridonidis T, Alexiou S, Zampakis P, Savvopoulos C, Vassilakos PJ, Matsouka P.
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.